DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale lessened its stake in DocuSign, Inc. (NASDAQ:DOCU) by 23.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,759 shares of the company’s stock after selling 9,702 shares during the period. DekaBank Deutsche Girozentrale’s holdings in DocuSign were worth $1,923,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in DOCU. Vanguard Group Inc. boosted its holdings in DocuSign by 2.4% during the third quarter. Vanguard Group Inc. now owns 20,982,387 shares of the company’s stock worth $881,260,000 after buying an additional 482,472 shares in the last quarter. Capital World Investors raised its position in shares of DocuSign by 128.3% in the first quarter. Capital World Investors now owns 5,683,838 shares of the company’s stock worth $608,853,000 after acquiring an additional 3,193,727 shares during the period. Morgan Stanley boosted its stake in shares of DocuSign by 1.7% during the 3rd quarter. Morgan Stanley now owns 3,219,450 shares of the company’s stock worth $135,217,000 after acquiring an additional 53,553 shares in the last quarter. Clearbridge Investments LLC grew its position in shares of DocuSign by 1.9% during the 1st quarter. Clearbridge Investments LLC now owns 3,186,783 shares of the company’s stock valued at $341,368,000 after acquiring an additional 58,555 shares during the period. Finally, Renaissance Technologies LLC increased its stake in shares of DocuSign by 0.3% in the 1st quarter. Renaissance Technologies LLC now owns 2,872,900 shares of the company’s stock valued at $167,490,000 after purchasing an additional 8,300 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insider Buying and Selling

In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the sale, the chief executive officer now directly owns 111,767 shares in the company, valued at approximately $6,847,964.09. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the transaction, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Peter Solvik sold 15,000 shares of the stock in a transaction that occurred on Tuesday, April 9th. The shares were sold at an average price of $60.00, for a total transaction of $900,000.00. Following the completion of the sale, the director now directly owns 783 shares of the company’s stock, valued at approximately $46,980. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 54,871 shares of company stock worth $3,176,199. 17.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on DOCU. Morgan Stanley upgraded DocuSign from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $49.00 to $64.00 in a research report on Tuesday, January 16th. Royal Bank of Canada reissued a “sector perform” rating and issued a $59.00 price target on shares of DocuSign in a research note on Friday. TheStreet upgraded shares of DocuSign from a “d+” rating to a “c-” rating in a research report on Tuesday, December 19th. JMP Securities reaffirmed a “market outperform” rating and set a $84.00 price objective on shares of DocuSign in a report on Friday. Finally, Wells Fargo & Company cut their target price on shares of DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research note on Monday, February 5th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $60.25.

DocuSign Trading Down 1.0 %

NASDAQ:DOCU opened at $58.90 on Friday. DocuSign, Inc. has a twelve month low of $38.11 and a twelve month high of $64.76. The company has a market cap of $12.10 billion, a P/E ratio of 163.62, a P/E/G ratio of 5.20 and a beta of 0.89. The company’s 50-day moving average price is $55.37 and its 200-day moving average price is $51.66.

DocuSign (NASDAQ:DOCU) last released its earnings results on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.06. The business had revenue of $712.39 million for the quarter, compared to analyst estimates of $698.05 million. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. On average, analysts expect that DocuSign, Inc. will post 0.86 earnings per share for the current year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.